Latest TriReme Medical Inc. Stories

Century Medical, Inc. Distributes TriReme Products in Japan PLEASANTON Calif. and SINGAPORE, April 22, 2013 /PRNewswire/ -- TriReme Medical, Inc. and its affiliates (TriReme) announced today that its Japanese partner, Century Medical, Inc. (CMI), has received Shonin approval for the Glider(TM) PTCA catheter indicated for treating the stenotic portion of coronary arteries or bypass grafts to improve myocardial perfusion. Combining a skived tip and a unique braided shaft, Glider(TM) is...

Chinese Partner, Weigao, is One of Largest Medical Device Players in the Middle Kingdom PLEASANTON, Calif. and SINGAPORE, March 26, 2013 /PRNewswire/ -- TriReme Medical, Inc. and its affiliates (TriReme) announced today that it has signed a comprehensive agreement with Weihai Weigao Medical Devices, Ltd for the distribution of its products in the People's Republic of China. Weigao will act as TriReme's master distributor by selling TriReme products directly to hospitals as well as...

PLEASANTON, Calif., Nov. 27, 2012 /PRNewswire/ -- TriReme Medical, Inc. and its affiliates (TriReme) announced today a new round of financing that brings a total of US$18 million into the group. The round is led by Luminor Capital of Singapore and includes major existing investors and new Asian investors. TriReme provides a range of innovative solutions for complex lesions and proceeds of the new round will go toward developing TriReme's pipeline of unique dilatation catheters and...

PLEASANTON, Calif., July 16 /PRNewswire/ -- TriReme Medical, Inc. (TMI) announced today that it has received FDA clearance for an expanded matrix of sizes for its unique Glider(TM) PTCA balloon catheter. Glider(TM) is now approved for the treatment of lesions in the coronary vasculature in balloon diameters from 1.5 - 3.5mm and in lengths from 4mm to 20mm. "Glider(TM) provides interventional cardiologists with an entirely new degree of control during the treatment of complex side...

PLEASANTON, Calif., June 19, 2012 /PRNewswire/ -- TriReme Medical, Inc. (TMI) announced today that it has received FDA clearance for an expanded matrix of sizes for its Chocolate(TM) PTA balloon catheter. Chocolate(TM) is now approved for the percutaneous transluminal treatment of lesions in the peripheral vasculature in balloon diameters from 2.0 - 4.0mm and in balloon lengths up to 120mm. "This latest regulatory approval broadening the available size matrix of the Chocolate(TM) PTA...

PLEASANTON, Calif., May 23, 2012 /PRNewswire/ -- TriReme Medical, Inc. (TMI) today announced approval by the U.S. Food and Drug Administration (FDA) of the Glider(TM) PTCA Catheter, indicated for treating the stenotic portion of coronary arteries or bypass grafts to improve myocardial perfusion. Glider(TM) is the world's only torqueable PTCA balloon catheter. Combined with its state of the art tip technology, Glider(TM) is designed to perform, even in the most challenging conditions....

PLEASANTON, Calif., Dec. 21, 2011 /PRNewswire/ -- TriReme Medical, Inc. ("TriReme"), a leading developer of innovative devices for the treatment of complex vascular disease, announced today that it has received 510(K) clearance from the U.S. Food and Drug Administration to market its Chocolate PTA balloon catheter ("Chocolate") for the treatment of occluded peripheral arteries. Chocolate was developed in collaboration with TriReme's subsidiary, Quattro Vascular Pte Ltd...

PLEASANTON, Calif., May 9, 2011 /PRNewswire/ -- TriReme Medical, Inc. (TriReme), a leading developer of innovative catheters and stents for the treatment of complex vascular disease, announced today the appointment of Mr. Supratim Bose and Mr. Michael Kleine to their Board of Directors. Mr. Bose, Founder and CEO of Bose Consulting Group, is based in Singapore and was until recently Company Group Chairman at Johnson & Johnson with responsibilities for all of the Medical Devices &...

PLEASANTON Calif., SINGAPORE and TOKYO, Jan. 10, 2011 /PRNewswire/ -- TriReme Medical, Inc. (TriReme) today announced that it has signed an exclusive distribution and sales agreement for TriReme's complete line of advanced peripheral and coronary balloon dilatation catheters with Century Medical, Inc. (CMI), a leading independent device distributor for the important Japanese market. TriReme recently received clearance from the U.S. Food and Drug Administration (FDA) for the GliderXtreme(TM)...

PLEASANTON, Calif., Oct. 11 /PRNewswire/ -- TriReme Medical, a leading developer of innovative catheters and stents for the treatment of complex vascular disease, announced today the closing of a $17M Round D financing. The financing was led by Bio*One Capital, a subsidiary of Singapore based EDB Investments ('EDBI') with strong support from current investors, Three Arch Partners and Adams Street Partners. "We are delighted to have Bio*One join our group of sophisticated blue chip...